Modeling of outcomes after radiotherapy

This research involves mathematical models that ideally allow the personalization of radiation treatment based on clinical and physiological features of the patient and the tumor. I am mainly interested in statistical methods to model the response of normal and cancerous tissues to inonizing radiation in order to predict normal tissue complication (NTCP) or tumor control probabilities (TCP), respectively. Besides physical treatment parameters such as delivered dose, such models can use biological and clinical factors as predictors, e.g. tumor stage, hypoxia, certain blood parameters etc.

Neben klassischen Ansätzen, die TCP oder NTCP in der Regel als generalisierte lineare Funktionen bestimmter Variablen modellieren, z. B. der auf den Tumor oder das Risikoorgan applizierten Dosis, gibt es einige datengesteuerte Ansätze, die versuchen, alle relevanten Variablen und ihre möglichen Wechselwirkungen einzubeziehen, um das gewünschte Ergebnis vorherzusagen. Insbesondere Methoden des maschinellen Lernens wie Support Vector Machines haben sich als wirksame Werkzeuge für dieses Ziel erwiesen. Darüber hinaus habe ich Überlebensanalysetechniken wie Frailty-Modelle und „Cure rate“ Modelle genutzt, um die latenten biologischen Prozesse zu berücksichtigen, die während der Zeit nach der Behandlung ablaufen und NTCP, TCP oder die Gesamtüberlebenswahrscheinlichkeit beeinflussen. Dieser Forschungsschwerpunkt war auch Thema meiner Habilitation an der Universitätsklinik Zürich mit dem Thema „Outcome modelling of oligometastases treated by stereotactic body radiotherapy“.

Ketogenic diet and tumor metabolism

Nutrition is a commonly and often emotionally discussed topic in relation to cancer prevention and treatment. Unfortunately, the scientific facts often get mixed up with personal opinions or currently held beliefs that might be outdated. Over the past years, more evidence has accumulated suggesting that cancer is not only a genetic disease, but also a metabolic one, with altered cellular metabolism possibly even the primal cause for malignancy. Thanks to the early work of Otto Warburg and colleagues we know for about 100 years now that rapidly growing tumor cells mainly rely on decomposition of glucose to lactate even if there is sufficient oxygen available which in normal cells would inhibit excessive lactate production. This phenomenon is known as “aerobic glycolysis” or the “Warburg effect” and is the underlying principle of positron emission tomography (PET) imaging with fluordeoxyglucose (FDG).
In den letzten Jahren haben sich immer mehr Hinweise darauf verdichtet, dass Krebs im Grunde eine Stoffwechselerkrankung ist, bei der ein veränderter Zellstoffwechsel möglicherweise sogar die Hauptursache für die Entstehung von bösartigen Tumoren ist. Dank der frühen Arbeiten von Otto Warburg und seinen Kollegen wissen wir seit etwa 100 Jahren, dass schnell wachsende Tumorzellen hauptsächlich auf die Umwandlung von Glukose zu Laktat angewiesen sind, selbst wenn ausreichend Sauerstoff vorhanden ist, der in normalen Zellen eine übermäßige Laktatproduktion hemmen würde. Dieses Phänomen ist als „aerobe Glykolyse” oder „Warburg-Effekt” bekannt und bildet die Grundlage für die Positronen-Emissions-Tomographie (PET) mittels Flurodeoxyglukose (FDG).

It appears that there is a strong interaction between the patient’s metabolism and that of the tumor. For example, more and more studies point towards a highly increased risk of persons with Metabolic Syndrome for developing cancers of various origins. Increased levels of glucose, insulin and insulin-like growth factor (IGF) 1 are discussed as possible causes. Patients with advanced cancers, on the other hand, exhibit an altered metabolic state characterized through chronic inflammation with concurrent insulin resistance of normal tissues and muscle protein loss. This indicates that such patients might have altered nutritional needs.

My interest mainly lies on the impact of a ketogenic diet on cellular metabolism. The ketogenic diet is a very low carbohydrate, moderately protein containing and high fat diet in which the chronically low insulin levels lead to an increased production of ketone bodies from fatty acids. This induces a metabolic state that is in some aspects similar to fasting. Contrary to normal cells, most malignant cells are unable to fully metabolize ketone bodies. In addition, emerging evidence suggest that ketone bodies possess anti-oxidative properties and are able to modulate the expression of certain genes in tumor cells in ways that suppress their growth.

Our KETOCOMP study was one of the worldwide largest studies on ketogenic diets and cancer and we have published several articles of the results in highly ranked journals.

The Corona Crisis and Transhumanism

Very early on, there were many indications that the so-called coronavirus pandemic was planned and aimed primarily at injecting as many people as possible with the novel mRNA gene therapies known as vaccines. My research deals, among other things, with questions such as how it was possible to fool such a large part of the population, what the background and effects of the government-imposed measures were, what the problems are with mass testing using PCR, and what the coronavirus crisis has to do with transhumanism. Transhumanism is an ideology that has many supporters among political and economic leaders and seeks to actively control human evolution through modern technology. Together with Prof. Dr. Dr. Harald Walch and Dr. Christopher Germann, I was involved in the development of a psychometric transhumanism questionnaire, which we used, for example, to show that people who have been vaccinated against Covid-19 have a stronger belief in transhumanist ideas than those who had not been vaccinated.